These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6568874)

  • 1. Purified mouse mammary tumor and lymphoid cells in immune assays.
    Blazar BA; Vanky F; Klein E
    Cancer Immunol Immunother; 1984; 18(3):174-8. PubMed ID: 6568874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isolated tumor lymphocytes alone and with adherent cells.
    Blazar BA; Galili N; Klein E
    Cancer Immunol Immunother; 1984; 18(3):179-84. PubMed ID: 6568875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors.
    Blazer BA; Heppner GH
    J Immunol; 1978 Jun; 120(6):1881-6. PubMed ID: 659882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
    Blazar BA; Miller FR; Heppner GH
    J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice.
    Ames IH; Gagne GM; Garcia AM; John PA; Scatorchia GM; Tomar RH; McAfee JG
    Cancer Immunol Immunother; 1989; 29(2):93-100. PubMed ID: 2720709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a cellular immune response in a highly cancer-susceptible C3H/He strain of mice and its nonfactor substrain C3H/f after the transplantation of a syngeneic mammary gland tumor].
    Razvorotneva VA; Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Gruntenko EV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):68-73. PubMed ID: 228516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
    Krueger JG; Segal RA; Moyer RC
    Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retardation and promotion of growth of spontaneously appearing tumors using immune lymphocytes previously exposed to embryonic antigens.
    Gorczynski RM; MacRae S
    Cancer Res; 1982 Mar; 42(3):784-90. PubMed ID: 7059976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.
    Blazar BA; Laing CA; Miller FR; Heppner GH
    J Natl Cancer Inst; 1980 Aug; 65(2):405-10. PubMed ID: 6931258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
    Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
    Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic responsiveness of regional lymphocytes in experimental cancer.
    Goldfarb PM; Hardy MA
    Cancer; 1975 Mar; 35(3):778-83. PubMed ID: 1111943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases.
    Yoshida K; Tachibana T
    J Natl Cancer Inst; 1985 Dec; 75(6):1049-58. PubMed ID: 2866267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of host T-cell subsets based on Lyt antigenic markers during the development of spontaneous C3H mammary carcinomas.
    Brodt P; Lala PK
    Cell Immunol; 1984 Apr; 84(2):427-32. PubMed ID: 6608412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory and stimulatory effect of spleen cells from tumour bearing animals on the growth of syngeneic tumour cells.
    Larsen FS; Spärck JV
    Acta Pathol Microbiol Scand C; 1978 Jun; 86C(3):131-9. PubMed ID: 716926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on splenocyte cytotoxicity against syngeneic mammary carcinomas of mice. 1. Reactivity of splenocytes from mice bearing mammary tumors against the corresponding and against other neoplasms.
    More R; Yron I; Weiss DW
    Isr J Med Sci; 1978 Jan; 14(1):146-61. PubMed ID: 204609
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular cytotoxicity and serum inhibition in normal mice following transfer of xenogeneic tumor-sensitized cells.
    Fisher B; Wolmark N; Saffer EA
    Cancer Res; 1979 Dec; 39(12):4772-6. PubMed ID: 498106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.